Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Christopher, Dittus"'
Autor:
Barbara Savoldo, Gianpietro Dotti, Allison M Deal, Jonathan S Serody, Christopher Dittus, Nicholas P Tschernia, Hillary Heiling, Catherine Cheng, Caroline Babinec, Megan Gonzalez, J Kaitlin Morrison, Anne W Beaven, William A Wood, Natalie S Grover
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Chimeric antigen receptor (CAR)-T cells targeting CD30 have demonstrated high response rates with durable remissions observed in a subset of patients with relapsed/refractory CD30+ hematologic malignancies, particularly classical Hodgkin lymphoma. Th
Externí odkaz:
https://doaj.org/article/37ff0a870b1541c7ae281d7f0e1e2333
Autor:
Christopher Dittus, Natalie Grover, Tarsheen Sethi, Jonathon B. Cohen, Alfredo Voloschin, Janhvi Rabadey, Xianming Tan, Anne Beaven, Steven I. Park
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 734-738 (2022)
Externí odkaz:
https://doaj.org/article/6fdb2b8ac5174e959f92c2353f2afae5
Autor:
Callie Berkowitz, Christopher Dittus
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Immunoglobulin light chain (AL) amyloidosis may be caused by a B-cell non-Hodgkin lymphoma (NHL) rather than a plasma cell neoplasm in rare cases, which presents unique diagnostic and management considerations. NHL associated with AL will often have
Externí odkaz:
https://doaj.org/article/aab2967b52654328a35c6c776aea9e3e
Autor:
Jessica D. Rich, Stephen M. Clark, Yuri Fedoriw, Valerie Jewells, William Wood, Christopher Dittus
Publikováno v:
Clinical Case Reports, Vol 7, Iss 10, Pp 1957-1961 (2019)
Abstract Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and m
Externí odkaz:
https://doaj.org/article/1b0d10f093df4669804bf8ceb9e25968
Autor:
Talal El Zarif, Amin H. Nassar, Elio Adib, Bailey G. Fitzgerald, Jiaming Huang, Tarek H. Mouhieddine, Paul G. Rubinstein, Taylor Nonato, Rana R. McKay, Mingjia Li, Arjun Mittra, Dwight H. Owen, Robert A. Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J. Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G. Lechner, Alexandra Drakaki, Javier Baena, Caroline A. Nebhan, Tarek Haykal, Michael A. Morse, Alessio Cortellini, David J. Pinato, Alessia Dalla Pria, Evan Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui-Lia, Danai Dima, Ryan W. Dobbs, Pauline Funchain, Rabia Saleem, Rachel Woodford, Georgina V. Long, Alexander M. Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G. Reid, Elizabeth Y. Chiao, Elad Sharon, Douglas B. Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U. Marron, Toni K. Choueiri, Lindsey R. Baden, Kathryn Lurain, Guru P. Sonpavde, Abdul Rafeh Naqash
Publikováno v:
Journal of Clinical Oncology.
PURPOSE Compared with people living without HIV (PWOH), people living with HIV (PWH) and cancer have traditionally been excluded from immune checkpoint inhibitor (ICI) trials. Furthermore, there is a paucity of real-world data on the use of ICIs in P
Autor:
Talal El Zarif, Amin Nassar, Elio Adib, Bailey Fitzgerald, Jiaming Huang, Tarek Mouhieddine, Taylor Nonato, Rana McKay, Mingjia Li, Arjun Mittra, Dwight Owen, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Brinda Emu, Adewunmi Falohun, Noha Abdel-Wahab, Anand Bankapur, Alexandra Reed, Ryan Dobbs, Chul Kim, Aakriti Arora, Neil Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa Lechner, Javier Espinar, Caroline Nebhan, Douglas Johnson, Tarek Haykal, Michael Morse, Alessio Cortellini, David Pinato, Alessia Dalla Pria, Mark Bower, Evan Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Pauline Funchain, Rabia Saleem, Rachel Woodford, Georgina Long AO, Alexander Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Ramya Ramaswami, Thomas Marron, Toni Choueiri, Kathryn Lurain, Lindsey Baden, Guru Sonpavde, Abdul Rafeh Naqash
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Timothy J. Voorhees, Anne W. Beaven, Christopher Dittus, George E Hucks, J. Kaitlin Morrison, Catherine Joyce Arago Cheng, Tammy Cavallo, Steven I. Park, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo, Natalie S. Grover
Publikováno v:
Blood. 140:12723-12724
Autor:
Christopher Dittus, Roy Ervin Strowd III, Kelly Hoye, Xianming Tan, Jordan Miller, Celeste Bello, Amir Khandani, Anne W. Beaven
Publikováno v:
Blood. 140:6616-6617
Publikováno v:
British Journal of Haematology. 198
Autor:
Kyle Wang, Raghuveer Ranganathan, Andrew Z. Wang, Tyler Walburn, Anne W. Beaven, Natalie S Grover, Colette J. Shen, Christopher Dittus
Publikováno v:
Leukemia & Lymphoma. 62:68-75
We analyzed 25 patients receiving whole brain radiation (WBRT) for secondary CNS lymphoma (SCNSL), grouped by consolidative intent (after complete/partial response, n = 13) vs. palliative intent (i...